•
Mar 31

CME Group Q1 2025 Earnings Report

CME Group reported record highs in revenue, adjusted operating income, adjusted net income, and adjusted EPS for Q1 2025.

Key Takeaways

CME Group delivered its strongest quarter ever with record financial results across key metrics, driven by increased trading volumes across all asset classes and a surge in demand amid economic uncertainty.

Revenue hit an all-time high at $1.6 billion, up from $1.4879 billion in Q1 2024.

Net income was $956.2 million, with adjusted net income at $1.0071 billion.

Average daily volume reached a record 29.8 million contracts across all asset classes.

Adjusted EPS rose to $2.80, reflecting robust operating performance and market engagement.

Total Revenue
$1.6B
Previous year: $1.49B
+7.5%
EPS
$2.8
Previous year: $2.5
+12.0%
ADV Contracts
29.77M
Previous year: 26.36M
+12.9%
Avg. Rate per Contract
$0.686
Previous year: $0.695
-1.3%
Cash and Equivalents
$1.41B
Previous year: $1.44B
-2.2%
Total Assets
$158B
Previous year: $132B
+19.5%

CME Group

CME Group

CME Group Revenue by Segment

CME Group Revenue by Geographic Location

Forward Guidance

CME Group anticipates continued strong engagement as clients navigate ongoing global risks, with a focus on expanding product offerings and optimizing performance.

Positive Outlook

  • Sustained demand across asset classes expected.
  • Continued innovation in product offerings.
  • Expansion in international ADV, up 19% YoY.
  • Robust clearing and transaction infrastructure.
  • Strong balance sheet and dividend history.

Challenges Ahead

  • Volatility in global economic conditions.
  • Technological transition challenges with cloud migration.
  • Potential regulatory changes increasing costs.
  • Dependency on trading volumes for revenue.
  • Exposure to FX and interest rate fluctuations.